BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16844250)

  • 1. Uric acid in CHF: marker or player in a metabolic disease?
    Doehner W; von Haehling S; Anker SD
    Int J Cardiol; 2007 Feb; 115(2):156-8. PubMed ID: 16844250
    [No Abstract]   [Full Text] [Related]  

  • 2. Uric acid, xanthine oxidase and heart failure: unresolved issues.
    Verdejo H; Alcaino H; Greig D; Garcia L; Pizarro M; Chiong M; Castro P; Lavandero S
    Eur J Heart Fail; 2008 Dec; 10(12):1271-2. PubMed ID: 19010082
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of uric acid in heart failure].
    Alcaíno H; Greig D; Castro P; Verdejo H; Mellado R; García L; Díaz-Araya G; Quiroga C; Chiong M; Lavandero S
    Rev Med Chil; 2011 Apr; 139(4):505-15. PubMed ID: 21879191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition.
    Harzand A; Tamariz L; Hare JM
    Congest Heart Fail; 2012; 18(3):179-82. PubMed ID: 22587748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Uric acid as a marker of pathophysiological mechanisms in patients with cardiovascular disease].
    Calberg MJ; Kjøller E
    Ugeskr Laeger; 2005 Oct; 167(40):3771-4. PubMed ID: 16221391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricaemia and congestive heart failure: causation or association?
    Gottlieb S
    Eur Heart J; 1998 Dec; 19(12):1746-7. PubMed ID: 9886713
    [No Abstract]   [Full Text] [Related]  

  • 7. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology.
    Hare JM; Johnson RJ
    Circulation; 2003 Apr; 107(15):1951-3. PubMed ID: 12707249
    [No Abstract]   [Full Text] [Related]  

  • 8. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?
    Duan X; Ling F
    Med Hypotheses; 2008; 70(3):578-81. PubMed ID: 17689199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid in chronic heart failure: a marker of chronic inflammation.
    Leyva F; Anker SD; Godsland IF; Teixeira M; Hellewell PG; Kox WJ; Poole-Wilson PA; Coats AJ
    Eur Heart J; 1998 Dec; 19(12):1814-22. PubMed ID: 9886724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uric acid as a prognostic marker in acute heart failure--new expectations from an old molecule.
    Doehner W; von Haehling S; Anker SD
    Eur J Heart Fail; 2007 May; 9(5):437-9. PubMed ID: 17433888
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in xanthine oxidase activity in patients with circulatory failure].
    Bakhtiiarov ZA
    Ter Arkh; 1989; 61(5):68-9. PubMed ID: 2781495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid in chronic heart failure.
    Doehner W; Anker SD
    Semin Nephrol; 2005 Jan; 25(1):61-6. PubMed ID: 15660337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ongoing search for a stratified medicine approach in heart failure.
    Tang WH
    J Am Coll Cardiol; 2008 Jun; 51(24):2310-2. PubMed ID: 18549914
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
    Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
    Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
    Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C
    Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid and cardiovascular risk.
    Parmar MS
    N Engl J Med; 2009 Jan; 360(5):539; author reply 540-1. PubMed ID: 19186310
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biomarkers in heart failure: are they clinically useful?].
    Kempf T; Wollert KC
    Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
    [No Abstract]   [Full Text] [Related]  

  • 18. Uric acid and cardiovascular risk.
    Oh J; Won HY; Kang SM
    N Engl J Med; 2009 Jan; 360(5):539-40; author reply 540-1. PubMed ID: 19186314
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical differences between heart failure versus ischemic patients].
    Pinelli M; Bindi M; Moroni F; Rosada J; Castiglioni M
    Recenti Prog Med; 2007; 98(7-8):378-83. PubMed ID: 17685185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study.
    Cingolani HE; Plastino JA; Escudero EM; Mangal B; Brown J; Pérez NG
    J Card Fail; 2006 Sep; 12(7):491-8. PubMed ID: 16952781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.